|
|
Volumn 5, Issue 2, 2006, Pages 99-100
|
|
The IBS market
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
4 AMINO 5 CHLORO N (8 METHYL 8 AZABICYCLO[3.2.1]OCT 3ALPHA YL) 2 (1 METHYL 2 BUTYNYLOXY)BENZAMIDE;
ALOSETRON;
AMITRIPTYLINE;
ANTIDIARRHEAL AGENT;
ASIMADOLINE;
BENZODIAZEPINE DERIVATIVE;
CHOLECYSTOKININ A RECEPTOR ANTAGONIST;
CILANSETRON;
DDP 225;
DDP 733;
DESIPRAMINE;
DEXLOXIGLUMIDE;
DEXTOFISOPAM;
DICYCLOVERINE;
HYOSCYAMINE;
LAXATIVE;
LOPERAMIDE;
LUBIPROSTONE;
MITEMCINAL;
NEPADUTANT;
PUMOSETRAG;
RAMOSETRON;
RENZAPRIDE;
SAREDUTANT;
SEROTONIN 3 ANTAGONIST;
SEROTONIN 4 AGONIST;
TACHYKININ RECEPTOR ANTAGONIST;
TALNETANT;
TEGASEROD;
TRICYCLIC ANTIDEPRESSANT AGENT;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
GASTROINTESTINAL AGENT;
ABDOMINAL DISCOMFORT;
ABDOMINAL PAIN;
ARTICLE;
BLOATING;
CLINICAL FEATURE;
CLINICAL TRIAL;
CONSTIPATION;
COST OF ILLNESS;
DIARRHEA;
DIET SUPPLEMENTATION;
DIET THERAPY;
DISEASE ASSOCIATION;
DISEASE SEVERITY;
DRUG ABSORPTION;
DRUG APPROVAL;
DRUG COST;
DRUG EFFICACY;
DRUG INDICATION;
DRUG MARKETING;
DRUG MECHANISM;
DRUG MONITORING;
DRUG SURVEILLANCE PROGRAM;
ECONOMIC EVALUATION;
EXERCISE;
FOOD AND DRUG ADMINISTRATION;
GASTROINTESTINAL SYMPTOM;
HEALTH CARE COST;
HUMAN;
INCIDENCE;
IRRITABLE COLON;
ISCHEMIC COLITIS;
LOW DRUG DOSE;
PATHOGENESIS;
PATHOPHYSIOLOGY;
PATIENT ADVOCACY;
PATIENT EDUCATION;
PREVALENCE;
PRIORITY JOURNAL;
QUALITY OF LIFE;
SEX DIFFERENCE;
DRUG INDUSTRY;
ECONOMICS;
DRUG INDUSTRY;
GASTROINTESTINAL AGENTS;
HUMANS;
IRRITABLE BOWEL SYNDROME;
|
|
EID: 33645057718
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd1961 Document Type: Article |
|
Times cited : (16)
|
|
References (4)
|
